Skip to main content
SpringerLink
Log in

The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism

  • Original Article
  • Angiogene Metalloprotein Tetracycline, Minocycl Doxycyc
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Abstract

The tetracycline analogs minocycline and doxycycline are inhibitors of metalloproteinases (MMPs) and have been shown to inhibit angiogenesis in vivo. To further study the mechanism of action of these compounds we tested them in an in vitro model of angiogenesis: aortic sprouting in fibrin gels. Angiogenesis was quantitated in this system by a unique application of planar morphometry. Both compounds were found to potently inhibit angiogenesis in this model. To further characterize the activity of these compounds against MMPs, we determined the IC50s of both compounds against representatives of three classes of metalloproteinases: fibroblast collagenase, stromelysin, and gelatinase A. Doxycycline was found to inhibit collagenase, gelatinase A and stromelysin with IC50s of 452 μM, 56 μM and 32 μM, respectively. Minocycline was found to inhibit only stromelysin in the micromolar range with an IC50 of 290 μM. Since these results suggest that these compounds may not have been inhibiting in vitro angiogenesis by an MMP-dependent mechanism, we decided to test the effects of the potent MMP inhibitor BB-94. This compound failed to inhibit aortic sprouting in fibrin gels, thus strongly suggesting that both doxycycline and minocycline act by an MMP-independent mechanism. These results have implications for the mechanism of action of tetracycline analogs, particularly where they are being considered for the treatment of disorders of extracellular matrix degradation including periodontal disease, arthritis, and tumor angiogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14: 53–65

    Google Scholar 

  2. Burns FR, Stack MS, Gray RD, Paterson CA (1989) Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci 30(7): 1569–1575

    Google Scholar 

  3. Campion C, Davidson AH, Dickens JP, Crimmin MJ (1990) Hydroxamic acid based collagenase inhibitors. British Biotechnology Patent WO 90/05719

  4. Cawston, TE, Barrett AJ (1979) A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem 99: 340–345

    Google Scholar 

  5. Davies B, Brown PD, East N, Crimmen MJ, Balkwill FR (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53: 2787–2791

    Google Scholar 

  6. DeClerck Y, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 52: 701–708

    Google Scholar 

  7. Dixit SN, Mainardi CL, Seyer JM, Kang AH (1979) Covalent structure of collagen: amino acid sequence of a2-CB5 of chick skin collagen containing the animal collagenase cleavage site. Biochemistry 18: 5416–5422

    Google Scholar 

  8. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, Mitchell MA (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162: 499–510

    Google Scholar 

  9. Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267(16): 10931–10934

    Google Scholar 

  10. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, Ramamurthy NS (1983) Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodontal Res 18: 516–526

    Google Scholar 

  11. Golub, LM, Ramamurthy NS, McNamara TS, Gomes B, Wolff M, Ciancio S, Schneir M, Perry H (1984) Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodonal disease. J Periodontal Res 19: 651–655

    Google Scholar 

  12. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM (1992) Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 19 (6): 927–938

    Google Scholar 

  13. Guerin C, Laterra J, Masnyk T, Golub LM, Brem H (1992) Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem Biophys Res Commun 188 (2): 740–745

    Google Scholar 

  14. Ingman T, Sorsa T, Suomalainen K, Halinen S, Lindy O, Lauhio H, Saari H, Konttinen YT, Golub LM (1993) Tetracycline inhibition and the cellular source of collagenase in gingival crevicular fluid in different periodontal diseases. A review article. J Periodontol 64 (2): 82–88

    Google Scholar 

  15. Khokha R (1994) Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor metalloproteinases-1. J Natl Cancer Inst 86(4): 299–304

    Google Scholar 

  16. Marcy AI, Eiberger LL, Harrison R, Chan HK, Hutchinson NI, Hagmann WK, Cameron PM, Boulton DA, Hermes JD (1991) Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form. Biochemistry 30: 6476–6483

    Google Scholar 

  17. Matrisian LM (1990) Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6(4): 121–125

    Google Scholar 

  18. Mignatti P, Tsuboi R, Robbins E, and Rifkin DB (1989) In-vitro angiogenesis on the human amniotic membrane: requirement of basic fibroblast growth factor-induced proteinases. J Cell Biol 108 (2): 671–682

    Google Scholar 

  19. Miller EJ, Harris ED, Chung E, Finch J, McCroskery PA, Butler WT (1976) Cleavage of type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens. Biochemistry 15: 787–792

    Google Scholar 

  20. Montesano D, Vassalli J-D, Baird A, Guillemin R, Orci L (1986) Basic fibroblast gowth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 83: 7297–7301

    Google Scholar 

  21. Mørk A, Geisler A (1993) Effects of minocycline on accumulation of cyclic AMP in cerebral cortex of rat. A comparison with lithium. Neuropharmacology 32(8): 793–798

    Google Scholar 

  22. Moscatelli D, Rifkin DB (1988) Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 948: 67–85

    Google Scholar 

  23. Neuvonen PJ (1976) Interactions with the absorption of tetracyclines. Drugs 11: 45–54

    Google Scholar 

  24. Nicosia RF, Madri JA (1987) The microvascular extracellular matrix: developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 128: 78–90

    Google Scholar 

  25. Pepper MS, Belin D, Montesano R, Orci L, Vassalli J-D (1990) Transforming growth factor beta 1 modulates basic fibroblastinduced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111: 743–755

    Google Scholar 

  26. Sotomayor EA, Teicher BA, Schwartz GN, Holden SA, Menon K, Herman TS, Frei E (1992) Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30 (5): 377–384

    Google Scholar 

  27. Stetler-Stevenson WG (1990) Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 9 (4): 289–303

    Google Scholar 

  28. Suomalainen K, Sorsa T, Golub LM, Ramamurthy N, Lee HM, Uitto VJ, Saari H, Konttinen YT (1992) Specificity of the anticollagenase action of tetracyclines: relevance to their anti-in flammatory potential. Antimicrob Agents Chemother 36 (1): 227–229

    Google Scholar 

  29. Suomalainen K, Halinen S, Ingman T, Lindy O, Saari H, Konttinen YT, Golub LM, Sorsa T (1992) Tetracycline inhibition identifies the cellular sources of collagenase in gingival crevicular fluid in different forms of periodontal diseases. Drugs Exp Clin Res 18 (3): 99–104

    Google Scholar 

  30. Tamargo RJ, Bok RA, Brem H (1991) Angiogenesis inhibition by minocycline. Cancer Res 51 (2): 672–675

    Google Scholar 

  31. Teicher BA, Sotomayor EA, Huang ZD (1992) Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52 (23): 6702–6704

    Google Scholar 

  32. Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, Bauer EA, Goldberg GI (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA 84 (19): 6725–6729

    Google Scholar 

  33. Zucker S, Lysik RM, Ramamurthy NS, Golub LM, Wieman JM, Wilkie DP (1985) Diversity of melanoma plasma membrane proteinases: inhibition of collagenolytic and cytolytic activities by minocycline. J Natl Cancer Inst 75 (3): 517–525

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cancer and Infectious Diseases Research, Upjohn Laboratories, The Upjohn Company, 7252-267-412, 49001, Kalamazoo, MI, USA

    S. Gilbertson-Beadling, E. A. Powers, M. Stamp-Cole, P. S. Scott, T. L. Wallace, J. Copeland, G. Petzold, S. Ledbetter, R. Poorman, J. W. Wilks & C. Fisher

  2. Medional Chemistry Research, Upjohn Laboratories, The Upjohn Company, 7252-267-412, 49001, Kalamazoo, MI, USA

    M. Mitchell

Authors
  1. S. Gilbertson-Beadling
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. A. Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Stamp-Cole
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. S. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. L. Wallace
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Copeland
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Petzold
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M. Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S. Ledbetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. R. Poorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J. W. Wilks
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. C. Fisher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gilbertson-Beadling, S., Powers, E.A., Stamp-Cole, M. et al. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother. Pharmacol. 36, 418–424 (1995). https://doi.org/10.1007/BF00686191

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00686191

Key words

Search

Navigation